Advancing peptide synthesis: enabling rapid production of structurally diverse peptides

Dr. Thomas L. Mindt, Professor of Bioinorganic Radiochemistry at the University of Vienna’s Institute of Inorganic Chemistry since 2020, is also a co-founder of the Ludwig Boltzman Institute Applied Diagnostics. There, he led the Imaging Biomarkers program from 2016 to 2023. Previously, he was a Professor in Radiopharmaceutical Chemistry at the University of Basel, Switzerland. His research focuses on developing new diagnostic probes and therapeutics for applications in nuclear oncology.

Tom approached Biotage to explore the potential for automated peptide synthesis in his special application, including click chemistry methods.